Free Trial
→ Your free book is about to disappear (From Profits Run) (Ad)tc pixel Free PMCB Stock Alerts

Nuvilex (PMCB) Financials

Nuvilex logo
$6.68 -0.96 (-12.54%)
Closing price 11/13/2026 03:52 PM Eastern
Extended Trading
$6.74 +0.06 (+0.82%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Nuvilex

Annual Income Statements for Nuvilex

This table shows Nuvilex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 -17 23 -23
Consolidated Net Income / (Loss)		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 0.33 31 -19
Net Income / (Loss) Continuing Operations		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 0.33 31 -19
Total Pre-Tax Income 		-6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 0.33 31 -19
Total Operating Income		 -6.07 -4.44 -6.98 -4.10 -3.83 -3.62 -4.39 -6.46 -8.52 -4.38 -6.85
Total Gross Profit		 -1.87 -1.97 -2.22 -1.56 -1.59 -1.43 -1.54 -1.23 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 1.87 1.97 2.22 1.56 1.59 1.43 1.54 1.23 0.00 0.00 0.00
Total Operating Expenses		 4.20 2.47 4.76 2.55 2.24 2.19 2.85 5.22 8.52 4.38 6.85
Selling, General & Admin Expense		 2.75 1.22 2.44 1.68 1.62 1.00 1.90 3.80 6.11 3.94 4.91
Research & Development Expense		 1.41 1.18 2.00 0.46 0.30 0.92 0.69 0.47 0.41 0.44 0.39
Impairment Charge		 - - - - - - - 0.00 2.00 0.00 1.55
Total Other Income / (Expense), net		 0.01 -0.00 0.15 0.03 -0.00 0.07 0.15 2.14 8.85 35 -13
Interest & Investment Income		 - - - - - 0.00 0.16 1.94 3.40 1.42 1.11
Other Income / (Expense), net		 0.01 0.00 0.15 0.03 -0.00 0.07 -0.00 0.20 5.45 34 -14
Income Tax Expense		 - - - - - - - - 0.00 0.00 0.00
Preferred Stock Dividends Declared		 - - - - - - - 0.00 18 7.29 3.78
Basic Earnings per Share		 ($0.01) ($0.01) ($0.01) $0.00 ($4.23) ($2.45) ($0.27) ($0.22) ($1.80) $3.19 ($2.77)
Weighted Average Basic Shares Outstanding		 752.40M 845.31M 968.64M 1.10B 903.81K 1.45M 15.52M 19.49M 9.58M 7.33M 8.38M
Diluted Earnings per Share		 ($0.01) ($0.01) ($0.01) $0.00 ($4.23) ($2.45) ($0.27) ($0.22) ($1.80) $3.19 ($2.77)
Weighted Average Diluted Shares Outstanding		 752.40M 845.31M 968.64M 1.10B 903.81K 1.45M 15.52M 19.49M 9.58M 7.33M 8.38M
Weighted Average Basic & Diluted Shares Outstanding		 752.40M 845.31M 968.64M 1.10B 903.81K 1.45M 20.75M - - - 10.74M

Quarterly Income Statements for Nuvilex

This table shows Nuvilex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -5.62 -2.58 21 -2.96 -3.05 8.78 -8.36 -8.42 -1.56 -4.87 -5.79
Consolidated Net Income / (Loss)		 -0.62 1.35 23 -1.47 -3.05 12 -8.36 -7.42 0.75 -4.39 -5.08
Net Income / (Loss) Continuing Operations		 -0.62 1.35 23 -1.47 -3.05 12 -8.36 -7.42 0.75 -4.39 -5.08
Total Pre-Tax Income 		-0.62 1.35 23 -1.47 -3.05 12 -8.36 -7.42 0.75 -4.39 -5.08
Total Operating Income		 -1.87 -3.17 -1.27 -1.11 -0.96 -1.04 -0.85 -1.38 -2.12 -2.51 -1.01
Total Gross Profit		 -0.62 1.09 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Cost of Revenue		 0.62 -1.09 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 1.25 4.26 1.27 1.11 0.96 1.04 0.85 1.38 2.12 2.51 1.01
Selling, General & Admin Expense		 0.48 3.16 1.17 1.01 0.84 0.92 0.75 1.23 2.02 0.90 0.95
Research & Development Expense		 0.13 0.09 0.10 0.10 0.12 0.13 0.10 0.14 0.09 0.06 0.06
Total Other Income / (Expense), net		 1.25 4.51 25 -0.36 -2.09 13 -7.51 -6.04 2.86 -1.88 -4.07
Interest & Investment Income		 0.88 0.75 0.55 0.38 0.26 0.23 0.22 0.21 0.23 0.46 0.41
Other Income / (Expense), net		 0.37 3.77 24 -0.75 -2.34 13 -7.73 -6.25 2.63 -2.34 -4.48
Income Tax Expense		 - - - - - - 0.00 - - - 0.00
Preferred Stock Dividends Declared		 5.00 3.93 2.83 1.49 0.00 2.97 0.00 1.00 2.30 0.48 0.70
Basic Earnings per Share		 ($0.65) - $1.90 ($0.39) ($0.44) $2.12 ($1.23) ($1.24) ($0.17) ($0.13) ($0.54)
Weighted Average Basic Shares Outstanding		 8.61M 9.58M 7.87M 7.64M 6.96M 7.33M 6.80M 6.80M 9.26M 8.38M 10.74M
Diluted Earnings per Share		 ($0.65) - $1.90 ($0.39) ($0.44) $2.12 ($1.23) ($1.24) ($0.17) ($0.13) ($0.54)
Weighted Average Diluted Shares Outstanding		 8.61M 9.58M 7.87M 7.64M 6.96M 7.33M 6.80M 6.80M 9.26M 8.38M 10.74M
Weighted Average Basic & Diluted Shares Outstanding		 8.46M 0.00 7.68M 6.97M 6.86M 0.00 6.80M 10.13M 10.74M 10.74M 10.74M

Annual Cash Flow Statements for Nuvilex

This table details how cash moves in and out of Nuvilex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Net Change in Cash & Equivalents		 -0.78 1.54 -2.40 -0.54 0.38 1.31 83 -17 -18 -35 3.43
Net Cash From Operating Activities		 -4.35 -3.34 -5.08 -2.88 -2.34 -3.33 -4.12 -3.79 -2.15 -2.98 -5.15
Net Cash From Continuing Operating Activities		 -4.35 -3.34 -5.08 -2.88 -2.34 -3.33 -4.12 -3.79 -2.15 -2.98 -5.15
Net Income / (Loss) Continuing Operations		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 0.33 31 -19
Consolidated Net Income / (Loss)		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.24 -4.32 0.33 31 -19
Non-Cash Adjustments To Reconcile Net Income		 2.59 1.13 1.84 1.02 1.22 0.37 0.11 0.82 1.14 -22 13
Changes in Operating Assets and Liabilities, net		 -0.89 -0.02 -0.09 0.17 0.28 -0.15 0.01 -0.30 -3.63 -11 1.70
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.00 -7.00 2.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.00 -7.00 2.00
Purchase of Investments		 - - - - - - - - 0.00 -7.00 -3.00
Sale and/or Maturity of Investments		 - - - - - - - - - 0.00 5.00
Net Cash From Financing Activities		 3.57 4.88 2.68 2.34 2.73 4.64 87 -14 -11 -25 6.58
Net Cash From Continuing Financing Activities		 3.57 4.88 2.68 2.34 2.73 4.64 87 -14 -11 -25 6.58
Repurchase of Preferred Equity		 - - - - -0.00 - - 0.00 -16 -22 -0.25
Repurchase of Common Equity		 - - - - - - 0.00 -14 -28 -2.54 -0.40
Issuance of Preferred Equity		 - - - 0.00 0.00 - - 0.00 34 0.00 6.18
Other Financing Activities, net		 - - - 0.00 -0.01 - 0.00 0.00 0.00 0.00 1.05
Effect of Exchange Rate Changes		 -0.00 0.00 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.00 -0.00 0.00
Cash Income Taxes Paid		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Nuvilex

This table details how cash moves in and out of Nuvilex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents		 -12 -11 -18 -12 -4.46 -1.21 -1.99 2.23 4.76 -1.56 -0.86
Net Cash From Operating Activities		 -0.18 -0.33 -0.37 -1.05 -0.51 -1.04 -1.99 -0.98 -0.79 -1.39 -0.78
Net Cash From Continuing Operating Activities		 -0.18 -0.33 -0.37 -1.05 -0.51 -1.04 -1.99 -0.98 -0.79 -1.39 -0.78
Net Income / (Loss) Continuing Operations		 -0.62 1.35 23 -1.47 -3.05 12 -8.36 -7.42 0.75 -4.39 -5.08
Consolidated Net Income / (Loss)		 -0.62 1.35 23 -1.47 -3.05 12 -8.36 -7.42 0.75 -4.39 -5.08
Non-Cash Adjustments To Reconcile Net Income		 0.95 0.19 -21 3.67 6.60 -12 8.03 -3.86 0.47 7.93 9.30
Changes in Operating Assets and Liabilities, net		 -0.51 -1.87 -3.16 -3.26 -4.06 -0.79 -1.67 10 -2.00 -4.93 -5.00
Net Cash From Investing Activities		 -5.00 - -7.00 - - - 0.00 -3.00 5.00 - 0.00
Net Cash From Continuing Investing Activities		 -5.00 - -7.00 - - - 0.00 -3.00 5.00 - 0.00
Net Cash From Financing Activities		 -7.04 -11 -10 -11 -3.95 -0.17 0.00 6.21 0.54 -0.17 -0.08
Net Cash From Continuing Financing Activities		 -7.04 -11 -10 -11 -3.95 -0.17 0.00 6.27 0.48 -0.17 -0.08
Repurchase of Preferred Equity		 -6.64 -9.52 -9.43 -9.34 -3.72 - 0.00 - -0.16 -0.08 -0.08
Effect of Exchange Rate Changes		 0.00 -0.00 0.00 0.00 -0.00 0.00 0.00 -0.00 0.00 0.00 -0.00

Annual Balance Sheets for Nuvilex

This table presents Nuvilex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
Total Assets		 7.16 8.67 6.41 5.78 6.17 7.40 91 73 60 55 47
Total Current Assets		 2.03 3.54 1.28 0.65 1.04 2.28 85 68 50 22 37
Cash & Equivalents		 1.92 3.46 1.06 0.52 0.89 2.20 85 68 50 15 19
Short-Term Investments		 - - - - - - - - 0.00 0.37 18
Prepaid Expenses		 0.11 0.07 0.22 0.14 0.14 0.07 0.09 0.11 0.26 0.22 0.10
Other Current Assets		 - - - - - - - - 0.00 2.92 0.24
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 5.13 5.13 5.13 5.13 5.13 5.13 5.13 5.13 9.46 33 9.33
Other Noncurrent Operating Assets		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 5.16 31 9.33
Total Liabilities & Shareholders' Equity		 7.16 8.67 6.41 5.78 6.17 7.40 91 73 60 55 47
Total Liabilities		 0.64 0.58 0.64 0.74 1.08 0.72 0.70 0.59 20 3.28 12
Total Current Liabilities		 0.64 0.58 0.64 0.74 1.03 0.72 0.70 0.59 7.42 2.91 0.83
Accounts Payable		 0.34 0.37 0.35 0.12 0.19 0.17 0.21 0.13 0.39 0.40 0.27
Accrued Expenses		 0.15 0.21 0.29 0.62 0.82 0.55 0.50 0.46 0.74 2.52 0.52
Dividends Payable		 - - - - - - - 0.00 6.30 0.00 0.03
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00 13 0.36 11
Other Noncurrent Operating Liabilities		 - - - - - - - 0.00 13 0.36 11
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - - - 0.00 12 0.00 1.27
Total Equity & Noncontrolling Interests		 6.52 8.09 5.77 5.04 5.09 6.68 90 73 28 52 33
Total Preferred & Common Equity		 6.52 8.09 5.77 5.04 5.09 6.68 90 73 28 52 33
Preferred Stock		 - - - - - - - 0.00 0.00 0.00 0.00
Total Common Equity		 6.52 8.09 5.77 5.04 5.09 6.68 90 73 28 52 33
Common Stock		 91 97 102 105 109 114 202 202 185 181 183
Retained Earnings		 -85 -89 -96 -100 -104 -107 -112 -116 -116 -85 -104
Treasury Stock		 - - - - - - 0.00 -14 -42 -45 -45
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.00 -0.00 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02

Quarterly Balance Sheets for Nuvilex

This table presents Nuvilex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 1/31/2024 7/31/2024 10/31/2024 1/31/2025 7/31/2025 10/31/2025 1/31/2026 7/31/2026
Total Assets		 71 70 55 44 45 56 56 37
Total Current Assets		 62 33 21 17 19 23 21 31
Cash & Equivalents		 61 33 21 16 13 15 20 18
Short-Term Investments		 - - - 0.37 0.26 0.20 0.37 13
Prepaid Expenses		 0.30 0.24 0.49 0.21 0.24 0.50 0.16 0.03
Other Current Assets		 - - - - 0.82 1.91 0.00 0.43
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 9.85 37 34 27 26 33 35 5.74
Other Noncurrent Operating Assets		 2.72 3.65 3.93 3.33 4.82 11 11 5.74
Total Liabilities & Shareholders' Equity		 71 70 55 44 45 56 56 37
Total Liabilities		 22 17 12 3.58 1.52 19 16 6.90
Total Current Liabilities		 7.54 7.47 4.78 1.19 1.06 1.58 1.68 0.77
Accounts Payable		 0.48 0.55 0.35 0.48 0.47 1.02 1.20 0.39
Accrued Expenses		 0.77 0.68 0.71 0.71 0.60 0.52 0.45 0.35
Dividends Payable		 6.28 6.23 3.72 0.00 - 0.04 0.03 0.03
Total Noncurrent Liabilities		 15 9.68 6.87 2.38 0.46 18 15 6.55
Other Noncurrent Operating Liabilities		 15 9.68 6.87 2.38 0.46 18 15 6.55
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 18 5.33 0.00 0.00 0.00 0.90 0.87 1.89
Total Equity & Noncontrolling Interests		 31 48 43 40 44 35 38 28
Total Preferred & Common Equity		 31 48 43 40 44 35 38 28
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 31 48 43 40 44 35 38 28
Common Stock		 189 183 181 181 182 181 183 182
Retained Earnings		 -117 -92 -94 -97 -93 -101 -100 -109
Treasury Stock		 -41 -43 -44 -44 -45 -45 -45 -45
Accumulated Other Comprehensive Income / (Loss)		 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02

Annual Metrics And Ratios for Nuvilex

This table displays calculated financial ratios and metrics derived from Nuvilex's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/30/2016 4/30/2017 4/30/2018 4/30/2019 4/30/2020 4/30/2021 4/30/2022 4/30/2023 4/30/2024 4/30/2025 4/30/2026
DEI Shares Outstanding		 772,083,226.00 875,308,610.00 1,013,260,644.00 1,126,904,505.00 1,481,471,172.00 2,385,125,674.00 0.00 17,443,385.00 8,464,824.00 6,863,699.00 10,735,649.00
DEI Adjusted Shares Outstanding		 772,083,226.00 875,308,610.00 1,013,260,644.00 1,126,904,505.00 1,481,471,172.00 2,385,125,674.00 0.00 17,443,385.00 8,464,824.00 6,863,699.00 10,735,649.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 -0.25 -2.04 3.40 -2.16
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 54.28% 26.73% -53.73% 40.44% 5.92% 7.27% -23.90% -42.24% 50.99% 1,054.00% -170.24%
EBIT Growth		 54.28% 26.73% -53.73% 40.44% 5.92% 7.27% -23.90% -42.24% 50.99% 1,054.00% -170.24%
NOPAT Growth		 54.20% 26.86% -57.16% 41.26% 6.69% 5.32% -21.23% -46.98% -88.54% 48.62% -9.59%
Net Income Growth		 38.92% 26.72% -53.68% 40.44% 5.91% 7.20% -19.37% -1.81% 107.73% 9,084.98% -163.36%
EPS Growth		 0.00% 0.00% 0.00% 100.00% 0.00% 42.08% 88.98% 18.52% -718.18% 277.22% -186.83%
Operating Cash Flow Growth		 4.69% 23.17% -52.10% 43.34% 18.75% -42.44% -23.61% 7.86% 43.29% -38.43% -73.02%
Free Cash Flow Firm Growth		 58.21% 17.08% -58.84% 45.99% 9.77% -13.23% -13.56% -49.23% 76.92% -4,102.54% 174.56%
Invested Capital Growth		 -13.57% 0.70% 2.81% -5.89% -8.64% 7.71% 1.44% 4.46% -241.92% 932.12% -105.69%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 45.39% -0.54% -2.11% -28.67% 29.97% -6.22% 14.78% 9.55% 32.10% 59.61% -392.97%
EBIT Q/Q Growth		 45.39% -0.54% -2.11% -28.67% 29.97% -6.22% 14.78% 9.55% 32.10% 59.61% -392.97%
NOPAT Q/Q Growth		 31.90% -0.54% -4.39% -29.73% 29.97% -8.54% 16.07% 8.56% -94.52% 32.66% -27.27%
Net Income Q/Q Growth		 21.89% -0.75% -2.10% -35.20% 29.53% -6.27% 9.37% 23.10% 129.30% 51.36% -491.92%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 100.00% 0.00% 60.03% 79.55% 0.00% 0.00% 0.00% -432.69%
Operating Cash Flow Q/Q Growth		 -3.01% 11.12% -12.73% 19.86% 0.93% -9.93% -6.51% 19.23% -2.12% -31.15% -7.34%
Free Cash Flow Firm Q/Q Growth		 24.87% 12.86% -12.02% -5.38% 27.35% 0.45% 17.04% 1.77% -117.48% -137.69% 620.09%
Invested Capital Q/Q Growth		 21.17% 1.69% 13.73% -4.59% 3.54% -3.96% -5.49% 5.77% 42.58% 647.37% 42.11%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.02% 100.03% 100.00% 100.00% 100.01% 100.09% 96.43% 69.02% -10.89% 104.84% 94.58%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -84.81% -60.83% -98.57% -75.26% -75.57% -60.35% -8.78% -5.31% 0.59% 67.08% -44.94%
Cash Return on Invested Capital (CROIC)		 -115.55% -102.97% -160.74% -88.22% -85.80% -97.97% -106.50% -154.36% 0.00% -124.06% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -84.81% -60.83% -98.57% -75.26% -75.57% -60.35% -8.78% -5.31% 0.53% 58.37% -44.28%
Return on Equity Simple (ROE_SIMPLE)		 -92.96% -54.95% -118.38% -80.71% -75.20% -53.17% -4.71% -5.94% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.25 -3.11 -4.89 -2.87 -2.68 -2.54 -3.07 -4.52 -8.52 -4.38 -4.80
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -46.69% -31.28% -50.65% -50.72% -51.28% -32.93% -2.57% 0.26% 15.60% 117.92% -56.07%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -30.82% -8.44% -14.41%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.40 -6.25 -3.07 29 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.06 -4.44 -6.83 -4.07 -3.83 -3.55 -4.40 -6.25 -3.07 29 -21
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 30.78 28.14 8.43 11.40 8.59 8.56 0.54 0.70 1.34 0.42 0.38
Price to Tangible Book Value (P/TBV)		 67.52 50.15 21.92 38.57 28.39 18.27 0.56 0.74 1.42 0.43 0.38
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.93 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 108.01% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 65.11 72.95 14.67 18.76 15.32 18.39 0.00 0.00 0.00 0.17 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.54 -0.58 -0.55 -0.44 -0.44 -0.52 -0.94 -0.96 -1.01 -0.65 -0.60
Leverage Ratio		 1.15 1.08 1.09 1.13 1.18 1.15 1.01 1.01 1.19 1.26 1.18
Compound Leverage Factor		 1.15 1.08 1.09 1.13 1.18 1.15 0.98 0.70 -0.13 1.32 1.12
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 1.46% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.90% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 30.03% 0.00% 3.67%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 98.54% 100.00% 100.00% 100.00% 69.97% 100.00% 96.33%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.63 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.03 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.89 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 169.77 219.65 20.96 19.86 -1.29 25.71 40.35 50.71 -0.92 3.98 -2.99
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.58% 12.98% 1.47%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.19 6.10 1.99 0.88 1.01 3.14 121.38 116.18 6.80 7.68 45.28
Quick Ratio		 3.01 5.97 1.65 0.69 0.87 3.04 121.24 115.99 6.76 6.60 44.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.78 -3.13 -4.97 -2.69 -2.42 -2.74 -3.12 -4.65 -1.07 -45 34
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -3,170.16 -2,034.22 0.00 0.00 -5,349.85 -900.90 -6,122.15 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -3,649.38 -2,169.89 0.00 0.00 -5,161.97 -1,093.53 -8,089.04 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -3,649.38 -2,169.89 0.00 0.00 -5,161.97 -1,093.53 -8,089.04 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 4.50 5.62 6.18 6.56 10.31 7.98 8.18 7.40 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 81.19 64.97 59.02 55.68 35.40 45.73 44.61 49.31 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3.03 3.05 3.14 2.95 2.70 2.91 2.95 3.08 -4.37 36 -2.07
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -0.48 0.02 0.09 -0.18 -0.25 0.21 0.04 0.13 -7.45 41 -38
Enterprise Value (EV)		 197 223 46 55 41 53 -39 -19 -1.33 6.09 -23
Market Capitalization		 201 228 49 57 44 57 48 51 37 22 13
Book Value per Share		 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $5.79 $4.17 $3.27 $7.56 $3.10
Tangible Book Value per Share		 $0.00 $0.01 $0.00 $0.00 $0.00 $0.00 $5.56 $3.96 $3.08 $7.33 $3.10
Total Capital		 6.52 8.09 5.77 5.04 5.16 6.68 90 73 40 52 35
Total Debt		 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -3.49 -5.04 -2.63 -2.09 -2.39 -3.77 -87 -70 -50 -16 -37
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.53 -0.51 -0.42 -0.60 -0.86 -0.65 -0.61 -0.48 -7.16 3.92 -0.49
Debt-free Net Working Capital (DFNWC)		 1.39 2.96 0.64 -0.09 0.04 1.55 85 68 43 19 37
Net Working Capital (NWC)		 1.39 2.96 0.64 -0.09 0.01 1.55 85 68 43 19 37
Net Nonoperating Expense (NNE)		 1.81 1.33 1.94 1.20 1.15 1.02 1.16 -0.20 -8.85 -35 15
Net Nonoperating Obligations (NNO)		 -3.49 -5.04 -2.63 -2.09 -2.39 -3.77 -87 -70 -44 -16 -37
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.01) ($0.01) ($0.01) $0.00 $0.00 ($2.45) ($0.27) ($0.22) ($1.80) $3.19 ($2.77)
Adjusted Weighted Average Basic Shares Outstanding		 848.05M 973.17M 1.04B 1.10B 903.81K 1.45M 15.52M 19.49M 9.58M 7.33M 8.38M
Adjusted Diluted Earnings per Share		 ($0.01) ($0.01) ($0.01) $0.00 $0.00 ($2.45) ($0.27) ($0.22) ($1.80) $3.19 ($2.77)
Adjusted Weighted Average Diluted Shares Outstanding		 848.05M 973.17M 1.04B 1.10B 903.81K 1.45M 15.52M 19.49M 9.58M 7.33M 8.38M
Adjusted Basic & Diluted Earnings per Share		 ($0.01) ($0.01) ($0.01) $0.00 $0.00 ($2.45) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 752.40M 845.31M 968.64M 1.10B 1.36B 1.45M 20.75M 0.00 0.00 0.00 10.74M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.25 -3.11 -4.89 -2.87 -2.68 -2.54 -3.07 -4.52 -4.56 -3.06 -3.71
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -5,090.34 -2,886.38 0.00 0.00 -8,446.88 -1,164.87 -8,637.13 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -3,569.43 -2,020.47 0.00 0.00 -5,912.75 -832.60 -6,040.10 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -5,090.34 -2,886.38 0.00 0.00 -8,446.88 -1,164.87 -8,637.13 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -3,569.43 -2,020.47 0.00 0.00 -5,912.75 -832.60 -6,040.10 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -314.19% 8,448.40% 8.29% -2.07%

Quarterly Metrics And Ratios for Nuvilex

This table displays calculated financial ratios and metrics derived from Nuvilex's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding		 8,615,640.00 8,464,824.00 8,464,824.00 7,679,045.00 6,968,134.00 6,863,699.00 6,863,699.00 6,795,779.00 10,134,160.00 10,735,649.00 10,735,649.00
DEI Adjusted Shares Outstanding		 8,615,640.00 8,464,824.00 8,464,824.00 7,679,045.00 6,968,134.00 6,863,699.00 6,863,699.00 6,795,779.00 10,134,160.00 10,735,649.00 10,735,649.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.65 -0.31 2.43 -0.39 -0.44 1.28 -1.22 -1.24 -0.15 -0.45 -0.54
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -7.23% 170.60% 663.51% -197.70% -119.89% 1,821.22% -137.50% -311.66% 115.64% -142.12% 36.02%
EBIT Growth		 -7.23% 170.60% 663.51% -197.70% -119.89% 1,821.22% -137.50% -311.66% 115.64% -142.12% 36.02%
NOPAT Growth		 -20.35% -400.75% 12.65% 45.07% 48.62% 67.07% 53.20% -24.41% -215.11% -68.60% -18.67%
Net Income Growth		 18.92% 1,165.95% 835.76% -152.67% -391.55% 772.47% -135.69% -404.78% 124.52% -137.39% 39.22%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 32.31% 0.00% -164.74% -217.95% 61.36% -106.13% 56.10%
Operating Cash Flow Growth		 67.31% -15.45% -208.85% 46.85% -187.91% -212.46% -434.15% 7.13% -54.32% -33.85% 60.84%
Free Cash Flow Firm Growth		 1,147.71% 660.59% -187.11% -232.03% -242.71% -1,075.64% 10.73% 101.84% 148.09% 187.79% 180.17%
Invested Capital Growth		 -361.44% -241.92% 84.91% 111.50% 163.93% 932.12% 524.26% -84.07% -173.50% -105.69% -110.29%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -179.19% 139.94% 3,714.84% -108.10% -78.23% 448.97% -174.46% 11.12% 106.77% -1,040.08% -13.10%
EBIT Q/Q Growth		 -179.19% 139.94% 3,714.84% -108.10% -78.23% 448.97% -174.46% 11.12% 106.77% -1,040.08% -13.10%
NOPAT Q/Q Growth		 7.18% -142.02% 59.92% 38.98% 13.18% -55.12% 43.05% -62.21% -119.89% 17.01% 59.91%
Net Income Q/Q Growth		 -122.21% 317.37% 1,639.17% -106.27% -107.23% 485.82% -171.15% 11.27% 110.07% -688.26% -15.65%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -120.53% -12.82% 581.82% -158.02% -0.81% 86.29% 23.53% -315.38%
Operating Cash Flow Q/Q Growth		 91.08% -88.00% -12.12% -182.55% 51.66% -104.04% -91.66% 50.88% 19.67% -76.98% 43.92%
Free Cash Flow Firm Q/Q Growth		 -19.40% -53.53% -455.59% 0.88% 12.88% -217.72% 67.46% 102.05% 2,173.35% 480.04% -70.29%
Invested Capital Q/Q Growth		 40.73% 42.58% 43.26% 159.57% 229.42% 647.37% -71.07% -97.76% -1,619.53% 42.11% 47.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 41.27% 224.60% 102.39% 79.34% 92.25% 102.00% 97.46% 97.29% 144.69% 90.54% 92.58%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -1.81% 0.59% 47.88% 44.68% 45.44% 67.08% -2.33% -17.78% -8.28% -44.94% -44.24%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -1,471.25% -390.09% -124.06% -149.91% -200.70% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -1.56% 0.53% 38.48% 35.31% 36.51% 58.37% -2.20% -17.57% -8.19% -44.28% -43.10%
Return on Equity Simple (ROE_SIMPLE)		 -3.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.31 -3.17 -1.27 -0.77 -0.67 -1.04 -0.59 -0.96 -2.12 -1.76 -0.70
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 1.05% 7.95% 37.57% -1.23% -5.17% 43.06% -17.53% -16.58% 7.35% -10.10% -13.77%
Return On Investment Capital (ROIC_SIMPLE)		 -4.17% -11.45% -2.66% -1.78% -1.67% -2.01% -1.36% -2.73% -5.56% -5.28% -2.56%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -1.50 0.60 23 -1.85 -3.30 12 -8.58 -7.62 0.52 -4.85 -5.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.50 0.60 23 -1.85 -3.30 12 -8.58 -7.62 0.52 -4.85 -5.49
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.22 1.34 0.72 0.73 0.70 0.42 0.41 0.46 0.37 0.38 0.37
Price to Tangible Book Value (P/TBV)		 1.37 1.42 0.74 0.75 0.72 0.43 0.42 0.48 0.39 0.38 0.37
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 3.38 3.35 2.33 0.93 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 29.62% 29.85% 42.86% 108.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.04 -1.01 -1.17 -1.11 -1.03 -0.65 -0.92 -0.98 -0.98 -0.60 -0.87
Leverage Ratio		 1.18 1.19 1.33 1.32 1.29 1.26 1.19 1.40 1.26 1.18 1.12
Compound Leverage Factor		 0.49 2.67 1.37 1.05 1.19 1.28 1.16 1.36 1.82 1.07 1.04
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 35.83% 30.03% 10.05% 0.00% 0.00% 0.00% 0.00% 2.50% 2.24% 3.67% 6.43%
Common Equity to Total Capital		 64.17% 69.97% 89.95% 100.00% 100.00% 100.00% 100.00% 97.50% 97.76% 96.33% 93.57%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.44 -0.72 0.87 -0.50 1.79 2.92 3.98 -2.01 -1.55 -1.89 -2.81
Noncontrolling Interest Sharing Ratio		 13.90% 10.58% 19.63% 20.98% 19.65% 12.98% 5.52% 1.13% 1.10% 1.47% 2.59%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.16 6.80 4.40 4.47 14.20 7.68 18.01 14.60 12.33 45.28 40.30
Quick Ratio		 8.12 6.76 4.37 4.36 14.03 6.60 17.01 13.06 12.24 44.87 39.70
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 9.21 4.28 -15 -15 -13 -42 -14 0.28 6.32 37 11
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 2.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 126.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -7.61 -4.37 -2.48 1.48 4.86 36 11 0.24 -3.57 -2.07 -1.08
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -11 -7.45 14 14 12 41 13 -1.24 -8.44 -38 -12
Enterprise Value (EV)		 -7.06 -1.33 -22 -14 -7.39 6.09 -15 -19 -28 -23 -19
Market Capitalization		 38 37 34 32 28 22 18 16 14 13 10
Book Value per Share		 $3.64 $3.27 $5.64 $5.66 $5.78 $7.56 $6.35 $5.18 $3.76 $3.10 $2.56
Tangible Book Value per Share		 $3.23 $3.08 $5.45 $5.46 $5.55 $7.33 $6.13 $4.96 $3.61 $3.10 $2.56
Total Capital		 49 40 53 43 40 52 44 36 39 35 29
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -63 -50 -62 -46 -35 -16 -33 -36 -43 -37 -31
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -7.24 -7.16 -7.23 -4.28 -0.99 3.92 4.61 5.84 -1.52 -0.49 -0.31
Debt-free Net Working Capital (DFNWC)		 54 43 25 17 16 19 18 21 19 37 30
Net Working Capital (NWC)		 54 43 25 17 16 19 18 21 19 37 30
Net Nonoperating Expense (NNE)		 -0.69 -4.51 -25 0.70 2.37 -13 7.77 6.45 -2.86 2.64 4.38
Net Nonoperating Obligations (NNO)		 -57 -44 -56 -42 -35 -16 -33 -36 -43 -37 -30
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.44) $2.12 ($1.23) ($1.24) ($0.17) ($0.13) ($0.54)
Adjusted Weighted Average Basic Shares Outstanding		 8.46M 9.58M 7.68M 6.97M 6.96M 7.33M 6.80M 6.80M 9.26M 8.38M 10.74M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.44) $2.12 ($1.23) ($1.24) ($0.17) ($0.13) ($0.54)
Adjusted Weighted Average Diluted Shares Outstanding		 8.46M 9.58M 7.68M 6.97M 6.96M 7.33M 6.80M 6.80M 9.26M 8.38M 10.74M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.46M 0.00 7.68M 6.97M 6.86M 0.00 6.80M 10.13M 10.74M 10.74M 10.74M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.31 -2.22 -0.89 -0.77 -0.67 -0.73 -0.59 -0.96 -1.48 -1.76 -0.70
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -2,749.96% 8,448.40% 0.81% 16.41% 17.51% 8.29% 0.00% -5.61% -17.47% -2.07% 0.00%

Financials Breakdown Chart

Key Financial Trends

PharmaCyte Biotech’s latest statements show a sizable near-term liquidity cushion, but the company remains pre-revenue in the quarters presented and continues to report losses. Its results also fluctuate significantly because of “other income or expense,” making operating performance and net income difficult to assess from headline figures alone.

In fiscal Q1 2027, which ended July 31, 2026, PMCB reported a $5.1 million net loss and no revenue. Cash used in operations was $781,000, while cash and cash equivalents declined by $865,000 during the quarter.

  • Cash and short-term investments totaled approximately $30.5 million at July 31, 2026, compared with current liabilities of about $769,000. That provides substantial coverage of near-term obligations, though it does not eliminate the need to monitor cash use.
  • Operating cash outflow improved to $781,000 in fiscal Q1 2027 from $1.4 million in fiscal Q4 2026 and $2.0 million in fiscal Q1 2026. Quarterly cash use has varied, so this improvement is not yet a clear sustained trend.
  • Cash-flow results differ materially from reported earnings: $9.3 million of non-cash adjustments partly offset the latest quarter’s $5.1 million net loss, while changes in operating assets and liabilities used $5.0 million. These items make net income an imperfect guide to cash needs.
  • The balance sheet’s investment mix changed: short-term investments were $12.8 million at July 31, 2026, while the prior supplied balance sheet showed $22.5 million of long-term investments and $372,000 of short-term investments. The data alone do not establish whether this reflects reclassification, sales, or other changes.
  • PMCB reported zero revenue in each income statement provided from fiscal Q1 2025 through fiscal Q1 2027. Without recurring revenue, the company remains reliant on its existing resources and any future financing to support operations.
  • The latest quarter’s $5.1 million net loss was larger than the $4.4 million loss in fiscal Q4 2026. The common-shareholder loss was $5.8 million after $705,000 in preferred dividends, equal to a loss of $0.54 per share versus $0.13 per share in Q4.
  • Other income and expense has been highly volatile: it was a $4.5 million expense in fiscal Q1 2027, following a $2.9 million gain in fiscal Q3 2026 and a $6.2 million expense in fiscal Q2 2026. These swings have materially affected reported earnings.
  • The accumulated deficit remains substantial: retained earnings were negative $109.5 million at July 31, 2026, compared with negative $93.3 million at July 31, 2025. This reflects the company’s ongoing history of losses.
11/14/26 05:42 AM ETAI Generated. May Contain Errors.

Nuvilex Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nuvilex's financial year ends in April. Their financial year 2026 ended on April 30, 2026.

Nuvilex's net income appears to be on an upward trend, with a most recent value of -$19.42 million in 2026, falling from -$6.06 million in 2016. The previous period was $30.66 million in 2025. View Nuvilex's forecast to see where analysts expect Nuvilex to go next.

Nuvilex's total operating income in 2026 was -$6.85 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $6.85 million

Over the last 10 years, Nuvilex's total revenue changed from $0.00 in 2016 to $0.00 in 2026, a change of 0.0%.

In the past 10 quarters, Nuvilex's cash and equivalents has ranged from $13.18 million in Q1 2026 to $61.21 million in Q3 2024, and is currently $17.74 million as of their latest financial filing in Q1 2027.

Nuvilex had total debt of $0.00 at the end of 2026, compared with none in 2025, and none in 2016.

Over the last 10 years, Nuvilex's book value per share changed from 0.01 in 2016 to 3.10 in 2026, a change of 36,820.2%.


Related Companies

Financial statements for NASDAQ:PMCB last updated on 11/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...
Monument Traders Alliance | Sponsoredtc pixel
Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...
Porter & Company | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...
Crypto 101 Media | Sponsoredtc pixel